Key result
Metabolic syndrome in hypertensive patients is linked to ~39 percentage points higher orthostatic instability.
Why the study?
Autonomic cardiovascular dysregulation is a key mechanism in hypertension and metabolic syndrome progression, motivating a comprehensive assessment via an active orthostatic test to determine the diagnostic significance of autonomic dysfunction parameters.
Does the presence of concomitant metabolic syndrome alter vegetative status and parameters of autonomic dysfunction during an active orthostatic test in patients with hypertension?
Observational (n=94)
Does the presence of concomitant metabolic syndrome alter vegetative status and parameters of autonomic dysfunction during an active orthostatic test in patients with hypertension?
Hypertensive patients with concomitant metabolic syndrome exhibit pronounced autonomic dysfunction—characterized by reduced baroreflex sensitivity, lower parasympathetic activity, and increased orthostatic instability—which can be assessed via an active orthostatic test to aid in cardiovascular risk stratification.
Answers are grounded in this paper and cite their sources.
Orthostatic testing detects greater autonomic impairment in hypertension with metabolic syndrome; leaves open whether it refines risk stratification or therapy.
Disorders of the autonomic regulation of the cardiovascular system are a key pathophysiological mechanism of the progression of hypertension and metabolic syndrome. The orthostatic test is a highly informative noninvasive method for assessing the functional state of baroreflective mechanisms and sympatho-parasympathetic regulation. The aim of the study was to comprehensively assess the vegetative status of patients with hypertension in combination with metabolic syndrome through an active orthostatic test to determine the diagnostic significance of various parameters of autonomic dysfunction. The study included 94 patients with verified hypertension, 49 of whom had concomitant metabolic syndrome. Methods of daily monitoring of blood pressure, analysis of heart rate variability, assessment of baroreflective sensitivity, spectral analysis of hemodynamic parameters were used. The results demonstrated a significant decrease in baroreflective sensitivity in the group with metabolic syndrome (8.2±3.1 vs 12.7±4.5 ms/mmHg, p<0.001), a decrease in parasympathetic activity according to the analysis of heart rate variability (RMSSD: 18.4±7.2 vs 28.6±9.4 ms, p<0.001), an increase in orthostatic instability (positive test in 67.2% vs 28.4%, p<0.001). An inverse correlation was established between body mass index and baroreflective sensitivity (r= -0.68, p<0.001), a direct relationship between waist circumference and the degree of orthostatic disorders (r=0.54, p<0.001). The data obtained indicate pronounced autonomic dysfunction in patients with comorbid pathology, requiring targeted correction to optimize prognosis and quality of life. The use of an active orthostatic test makes it possible to stratify the risk of cardiovascular complications and personalize therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Shvan et al. (2026) conducted an observational in Hypertension with or without concomitant metabolic syndrome (n=94). Concomitant metabolic syndrome vs. Hypertension without metabolic syndrome was evaluated on Orthostatic instability (positive active orthostatic test) (p=<0.001). Concomitant metabolic syndrome in hypertensive patients was associated with higher orthostatic instability and lower baroreflective sensitivity.
Synapse has enriched 10 related papers. Consider them for comparative context: